Home » Topics » BioWorld Science

BioWorld Science
RSS

Pharmacokinetic profile of Taisho's ACAT inhibitor

Nov. 18, 1997

New cardiotonic candidate studied, rejected at Fujisawa

Nov. 18, 1997

Potential of rhM-CIF in rheumatoid arthritis suggested by animal studies

Nov. 18, 1997

Warner-Lambert describes novel anticonvulsants related to gabapentin

Nov. 18, 1997

SUNY discloses new taxoids

Nov. 18, 1997

Prodrugs of thrombin inhibitors prepared at BMS

Nov. 18, 1997

Searle reports inhibitors of iNOS

Nov. 18, 1997

New MMP inhibitors from Pharmacia & Upjohn

Nov. 18, 1997

New ECE inhibitors patented by Roussel Uclaf

Nov. 18, 1997

New antidepressant and cognition enhancer developed in Russia

Nov. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
DEE-lightful: Praxis’ phase II results allow stock to flex its muscle
BioWorld
Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...